TSVT - 2seventy bio, Inc.
4.99
-0.010 -0.200%
Share volume: 1,139,343
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$5.00
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-10-2023 | 08-14-2023 | 11-14-2023 | 03-07-2024 | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-25-2025 | |
| Total revenue | 41.621 M | 36.048 M | 12.034 M | 10.684 M | 12.435 M | 8.967 M | 13.534 M | 2.926 M | |
| Cost of revenue | 641.000 K | 907.000 K | 551.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 40.980 M | 35.141 M | 11.483 M | 10.684 M | 12.435 M | 8.967 M | 13.534 M | 2.926 M | |
| -14.25% | -67.32% | -6.96% | 16.39% | -27.89% | 50.93% | -78.38% | |||
| Operating expenses | 88.966 M | 79.469 M | 64.319 M | 67.418 M | 56.590 M | 25.870 M | 21.204 M | 17.177 M | |
| Selling general and admin | 20.720 M | 19.489 M | 13.004 M | 16.201 M | 12.659 M | 9.857 M | 12.884 M | 8.524 M | |
| Research and development | 68.246 M | 59.980 M | 51.315 M | 51.217 M | 43.931 M | 16.013 M | 8.320 M | 8.653 M | |
| Total expenses | 93.261 M | 83.986 M | 69.278 M | 70.565 M | 59.859 M | -11.951 M | 27.475 M | 26.192 M | |
| -9.95% | -17.51% | 1.86% | -15.17% | -119.97% | 329.90% | -4.67% | |||
| Operating income | -51.640 M | -47.938 M | -57.244 M | -59.881 M | -47.424 M | -27.069 M | -13.941 M | -23.266 M | |
| Ebit | -51.640 M | -47.938 M | -57.244 M | -59.881 M | -47.424 M | -25.635 M | -12.788 M | -22.152 M | |
| Pretax income | -47.021 M | -42.089 M | -71.638 M | -56.822 M | -52.673 M | 24.879 M | -9.933 M | -19.520 M | |
| -10.49% | 70.21% | -20.68% | -7.30% | -147.23% | -139.93% | 96.52% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -47.021 M | -42.089 M | -71.638 M | -56.822 M | -52.673 M | 0.000 | 0.000 | 0.000 | |
| 10.49% | -70.21% | 20.68% | 7.30% | 100.00% | |||||
| Net income | -47.021 M | -42.089 M | -71.638 M | -56.822 M | -52.673 M | 24.879 M | -9.933 M | -19.520 M | |
| 10.49% | -70.21% | 20.68% | 7.30% | 147.23% | -139.93% | -96.52% |
